Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research



Rating:

Share or cite this content

Citations should be made in the following way:
S. Georgios, G. Ntaliarda (ntaliarda@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. De Chateau (dechateau@buzzardpharma.com / Buzzard Pharmaceuticals, K. Institute Science Park,Stockcholm ), G. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), U. Hospital, L. University and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL),Munich). LSC - 2021 - Preclinical evaluation of IL-1ß inhibition against KRAS-mutant lung adenocarcinoma. 1122

Member's Comments

No comment yet.

Related content which might interest you: PP136 – Preclinical evaluation of IL-1ß inhibition against KRAS-mutant lung adenocarcinoma Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 LSC - 2021 - Regulation of PA200 in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 LSC - 2021 - Macrophages in lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2018 - A requirement for mast cells in lung adenocarcinoma Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 Source: Eur Respir J 2012; 39: 172-179 Year: 2012 Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 Source: Eur Respir J 2011; 39: 172-179 Year: 2012 Metaanalysis of ROS1-positive lung cancer cases Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Clinical relevance of p53 and K-ras mutations in nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation Source: Eur Respir J 2011; 37: 624-631 Year: 2011 Role of bronchoscopy in lung cancer translational research: Tumor harvest for the lung cancer mutation consortium (LCMC) studies Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centre Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011